The importance of using scientific principles in the development of medicinal agents from plants

Academic Medicine

Volumn 76, Issue 3, 2001, Pages 238-247

  Talalay, Pamela ^a   Talalay, Paul ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; PLANT EXTRACT; SULFORAPHANE;

ALTERNATIVE MEDICINE; CRUCIFERA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG LEGISLATION; DRUG PURITY; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; GINGER; HEALTH CARE POLICY; MEDICINAL PLANT; PRIORITY JOURNAL; REVIEW;

EID: 0035098686     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-200103000-00010     Document Type: Review

References (41)

1. Why bogus therapies seem to work
2. Harmless herbs? A review of the recent literature
3. Dietary supplements may test consumers' health
4. Contamination of botanical dietary supplements by Digitalis lanata
5. Nephropathy caused by Chinese herbs in the UK
6. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs
7. Letter to health care professionals: FDA concerned about botanical products, including dietary supplements containing aristolochic acid
8. Letter to industry - FDA concerned about botanical products, including dietary supplements containing aristolochic acid
9. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)
10. Cancer and herbs
11. Adulterants in Asian patent medicines
12. Update: Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan - United States, through August 24, 1990. Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome
13. On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome
14. Indavir concentrations and St. John's wort
15. Acute heart transplant rejection due to St. John's wort
16. Drug interactions with St. John's wort
17. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
18. Alternative medicine: The risks of untested and unregulated remedies
19. Alternative medicine meets science
20. Clinical development plan: Curcumin
21. Cytotoxicity and cytoprotective activities of natural compounds: The case of curcumin
22. Rapid detection of inducers of enzymes that protect against carcinogenesis
23. A major inducer of anti-carcinogenic protective enzymes from broccoli: Isolation and elucidation of structure
24. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates
25. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
26. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables
27. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids
28. The FDA, regulation, and the risk of stroke
29. Phenylpropanolamine and the risk of hemorrhagic stroke